Found 19 matching trials
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
PHASE4Changes in chelation treatment and transfusion practices, during the past t...
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment
PHASE4Multi-center, non-randomized, open-label, single-dose, parallel group study...
Location
Hôpital Maisonneuve-Rosemont
Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
PHASE4Randomized, single-dose, double-blind, placebo and active controlled, four-...
Role of Vitamin C to Augment Iron Chelation With DFP or DFX
PHASE2role of Vit C to Augment iron chelation with DFP or DFX in thalassemic pati...
Location
Pediatric Hematology clinic, Ain Shams University Egypt
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
PHASE4Multi-center, non-randomized, open-label, single-dose, parallel group study...
Location
University of Miami
Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis
PHASE2The alteration of iron metabolism is reported in animal models of amyotroph...
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease
PHASE2This study evaluates the effect of iron chelation as a therapeutic strategy...
Location
Medizinische Universitat Innsbruck
Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients
NABackground: Three iron chelators now available on the market differ in toxi...
Location
Multiple Locations
Pharmacokinetic Study of Deferiprone in Paediatric Patients
PHASE2Deferiprone (DFP) is the most extensively studied oral iron chelator to dat...
Location
Department of Medical and Public Health Services of the Ministry of Health
A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers
PHASE1Single center, randomized, double-blind, placebo-controlled, adaptive seque...
Location
Algorithme Pharma Inc.